vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and WESTAMERICA BANCORPORATION (WABC). Click either name above to swap in a different company.

WESTAMERICA BANCORPORATION is the larger business by last-quarter revenue ($63.3M vs $40.7M, roughly 1.6× PETMED EXPRESS INC). WESTAMERICA BANCORPORATION runs the higher net margin — 43.9% vs -26.0%, a 69.9% gap on every dollar of revenue. On growth, WESTAMERICA BANCORPORATION posted the faster year-over-year revenue change (-9.0% vs -23.3%). WESTAMERICA BANCORPORATION produced more free cash flow last quarter ($119.7M vs $-9.2M). Over the past eight quarters, WESTAMERICA BANCORPORATION's revenue compounded faster (-8.6% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Westamerica Bancorporation is a regional bank holding company headquartered in California, U.S. It operates via its wholly owned banking subsidiary to provide full-spectrum retail and commercial banking services, including deposit products, business and consumer loans, wealth management, and payment services, primarily serving individual consumers, SMEs and local institutional clients in northern and central California.

PETS vs WABC — Head-to-Head

Bigger by revenue
WABC
WABC
1.6× larger
WABC
$63.3M
$40.7M
PETS
Growing faster (revenue YoY)
WABC
WABC
+14.3% gap
WABC
-9.0%
-23.3%
PETS
Higher net margin
WABC
WABC
69.9% more per $
WABC
43.9%
-26.0%
PETS
More free cash flow
WABC
WABC
$128.9M more FCF
WABC
$119.7M
$-9.2M
PETS
Faster 2-yr revenue CAGR
WABC
WABC
Annualised
WABC
-8.6%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
WABC
WABC
Revenue
$40.7M
$63.3M
Net Profit
$-10.6M
$27.8M
Gross Margin
23.3%
Operating Margin
-25.7%
59.8%
Net Margin
-26.0%
43.9%
Revenue YoY
-23.3%
-9.0%
Net Profit YoY
-1392.6%
-12.3%
EPS (diluted)
$-0.50
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
WABC
WABC
Q4 25
$40.7M
$63.3M
Q3 25
$44.4M
$63.7M
Q2 25
$51.2M
$64.6M
Q1 25
$50.8M
$66.4M
Q4 24
$52.0M
$69.6M
Q3 24
$58.0M
$74.1M
Q2 24
$66.2M
$74.3M
Q1 24
$65.1M
$75.8M
Net Profit
PETS
PETS
WABC
WABC
Q4 25
$-10.6M
$27.8M
Q3 25
$-8.5M
$28.3M
Q2 25
$-34.2M
$29.1M
Q1 25
$-11.6M
$31.0M
Q4 24
$-707.0K
$31.7M
Q3 24
$2.3M
$35.1M
Q2 24
$3.8M
$35.5M
Q1 24
$-5.0M
$36.4M
Gross Margin
PETS
PETS
WABC
WABC
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
WABC
WABC
Q4 25
-25.7%
59.8%
Q3 25
-18.9%
59.5%
Q2 25
-66.7%
60.5%
Q1 25
-11.9%
63.0%
Q4 24
-0.9%
62.8%
Q3 24
1.0%
64.5%
Q2 24
6.6%
64.8%
Q1 24
-5.9%
65.2%
Net Margin
PETS
PETS
WABC
WABC
Q4 25
-26.0%
43.9%
Q3 25
-19.2%
44.3%
Q2 25
-66.7%
45.0%
Q1 25
-22.9%
46.7%
Q4 24
-1.4%
45.6%
Q3 24
4.0%
47.3%
Q2 24
5.7%
47.8%
Q1 24
-7.7%
48.0%
EPS (diluted)
PETS
PETS
WABC
WABC
Q4 25
$-0.50
$1.12
Q3 25
$-0.41
$1.12
Q2 25
$-1.65
$1.12
Q1 25
$-0.56
$1.16
Q4 24
$-0.03
$1.19
Q3 24
$0.11
$1.31
Q2 24
$0.18
$1.33
Q1 24
$-0.24
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
WABC
WABC
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$933.5M
Total Assets
$88.0M
$6.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
WABC
WABC
Q4 25
$26.9M
Q3 25
$36.1M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
Q3 24
$52.0M
Q2 24
$46.0M
Q1 24
$55.3M
Stockholders' Equity
PETS
PETS
WABC
WABC
Q4 25
$32.8M
$933.5M
Q3 25
$43.1M
$931.6M
Q2 25
$51.5M
$921.8M
Q1 25
$85.1M
$923.1M
Q4 24
$96.2M
$890.0M
Q3 24
$96.4M
$909.0M
Q2 24
$93.5M
$815.6M
Q1 24
$96.7M
$791.7M
Total Assets
PETS
PETS
WABC
WABC
Q4 25
$88.0M
$6.0B
Q3 25
$100.3M
$5.9B
Q2 25
$109.8M
$5.8B
Q1 25
$148.7M
$6.0B
Q4 24
$144.8M
$6.1B
Q3 24
$146.0M
$6.2B
Q2 24
$152.7M
$6.3B
Q1 24
$169.9M
$6.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
WABC
WABC
Operating Cash FlowLast quarter
$-9.2M
$121.9M
Free Cash FlowOCF − Capex
$-9.2M
$119.7M
FCF MarginFCF / Revenue
-22.7%
189.0%
Capex IntensityCapex / Revenue
0.1%
3.5%
Cash ConversionOCF / Net Profit
4.38×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$213.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
WABC
WABC
Q4 25
$-9.2M
$121.9M
Q3 25
$-2.2M
$29.4M
Q2 25
$-12.3M
$23.5M
Q1 25
$7.0M
$42.4M
Q4 24
$-1.2M
$141.6M
Q3 24
$7.4M
$40.6M
Q2 24
$-8.5M
$19.0M
Q1 24
$7.1M
$52.2M
Free Cash Flow
PETS
PETS
WABC
WABC
Q4 25
$-9.2M
$119.7M
Q3 25
$-4.8M
$28.7M
Q2 25
$-13.6M
$22.8M
Q1 25
$4.6M
$42.2M
Q4 24
$-1.9M
$139.8M
Q3 24
$6.1M
$40.1M
Q2 24
$-9.2M
$18.6M
Q1 24
$5.9M
$52.1M
FCF Margin
PETS
PETS
WABC
WABC
Q4 25
-22.7%
189.0%
Q3 25
-10.8%
45.1%
Q2 25
-26.5%
35.3%
Q1 25
9.1%
63.5%
Q4 24
-3.7%
201.0%
Q3 24
10.6%
54.1%
Q2 24
-13.9%
25.0%
Q1 24
9.0%
68.7%
Capex Intensity
PETS
PETS
WABC
WABC
Q4 25
0.1%
3.5%
Q3 25
5.9%
1.1%
Q2 25
2.5%
1.1%
Q1 25
4.7%
0.3%
Q4 24
1.5%
2.5%
Q3 24
2.2%
0.7%
Q2 24
1.0%
0.6%
Q1 24
1.9%
0.2%
Cash Conversion
PETS
PETS
WABC
WABC
Q4 25
4.38×
Q3 25
1.04×
Q2 25
0.81×
Q1 25
1.37×
Q4 24
4.47×
Q3 24
3.18×
1.16×
Q2 24
-2.27×
0.54×
Q1 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

WABC
WABC

Segment breakdown not available.

Related Comparisons